Related Experiment Video
Updated: May 20, 2026
03:50
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Constipation in Iran: SEPAHAN Systematic Review No. 5
Niloufar Iraji1, Ammar Hassanzadeh Keshteli, Shirin Sadeghpour
1Medical Students' Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
International Journal of Preventive Medicine
|July 25, 2012
Summary
Constipation prevalence in Iran is high, affecting 1.4-37% of the population. Further research is needed to understand risk factors and improve quality of life for those with constipation.
Area of Science:
- Gastroenterology
- Public Health
Background:
- Constipation significantly impacts patient well-being and quality of life.
- Understanding the epidemiology of constipation in Iran is crucial.
Purpose of the Study:
- To systematically review existing studies on constipation prevalence in Iran.
- To identify the prevalence rates of general and functional constipation within the Iranian population.
Main Methods:
- Comprehensive literature search of major scientific databases (PubMed, Google Scholar) and Iranian databases (SID, Iran Medex, Magiran).
- Inclusion of 10 studies that reported constipation prevalence data in Iran.
Main Results:
- The overall prevalence of constipation in Iran was found to range widely from 1.4% to 37%.
- Functional constipation prevalence was reported between 2.4% and 11.2%.
- Key demographic factors such as gender, age, socioeconomic status, and education level appear to influence constipation rates.
Conclusions:
- Constipation represents a significant public health concern in Iran due to its high prevalence.
- There is a notable lack of data on the natural history, quality of life, and risk factors associated with constipation in Iran.
- Population-based studies are essential to comprehensively investigate the epidemiological aspects of constipation in the region.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:25Assessment of the Rectum and Anus
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:20Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: